Cefuzrom CV 250 Tablet is a broad-spectrum antibiotic used to treat bacterial infections effectively. It combines Cefuroxime (250 mg), a second-generation cephalosporin antibiotic, with Clavulanate (125 mg), a beta-lactamase inhibitor that enhances the antibiotic’s effectiveness against resistant bacteria. This combination works synergistically to eliminate infections caused by a wide range of bacteria by preventing bacterial cell wall synthesis and inhibiting bacterial resistance mechanisms.
Cefuzrom CV 250 is particularly effective against respiratory tract infections, urinary tract infections (UTIs), skin and soft tissue infections, sinusitis, tonsillitis, bronchitis, pneumonia, and other bacterial infections. The addition of Clavulanate ensures that bacteria producing beta-lactamase enzymes do not neutralize the antibiotic, making it more potent against resistant strains.
This formulation is widely prescribed for adults and children, ensuring quick relief and faster recovery from infections. It is generally well-tolerated when taken as directed, with a short treatment duration and high efficacy. It is advisable to complete the full course of the medication as prescribed by a healthcare professional to prevent antibiotic resistance and ensure complete bacterial eradication.